Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 0.34 0.14 0.00 151.85% -
EBITDA 0.33 0.02 -0.03 1710.50% 1230.00%
Op. profit margin(%) 70.32 13.41 - 424.51% -
Net Profit 0.33 0.02 -0.03 1710.50% 1230.00%
EPS 0.37 0.03 -0.05 1133.33% 840.00%
* Standalone data
Punctual Trading approves Q2FY27 financial results and appoints new statutory auditors
BSE India
Punctual Trading approves its unaudited standalone financial results for the quarter and half-year ended September 30, 2026. The board notes the resignation of M/s SVP & Associates as statutory auditors and approves the appointment of M/s Shah & Mantri as the new auditors. Additionally, the company approves transitioning its Registrar and Share Transfer Agent from MUFG Intime India Private Limited to Purva S.
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 0.00 0.00 0.00 - -
EBITDA 0.32 0.45 0.39 -28.23% -17.30%
Net Profit 0.22 0.33 0.29 -32.68% -24.46%
EPS 2.22 3.30 5.51 -32.73% -59.71%
* Standalone data
138.70
-5.00%
Sai Urja Indo Ventures board approves H1FY27 results and notes independent director resignation
BSE India
Sai Urja Indo Ventures board approves unaudited standalone and consolidated financial results for the half-year ended September 30, 2026. The board takes note of the resignation of Non-Executive Independent Director Mr. Abhishek Jain, effective November 2026. Additionally, the company appoints Mr. Gopal Shrikant Kabra as an Additional Non-Executive Independent Director starting November 16, 2026, until the next General Meeting.
94.99
1.07%
KS Smart Technologies approves Q2FY27 results and subsidiary amalgamation scheme
BSE India
KS Smart Technologies reports its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The statutory auditors issue an unqualified opinion on these financial results. Additionally, the board approves the scheme of amalgamation to merge its wholly owned subsidiary, KS Smart Solutions Private Limited, into the company. The merger remains subject to approval from the National Company Law Tribunal, Chennai Bench, and other regulatory authorities.
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 0.15 2.35 0.00 -93.62% -
EBITDA -0.21 -0.07 -0.03 -206.55% -507.67%
Op. profit margin(%) -146.03 -3.48 - -4096.13% -
Net Profit -0.21 -0.07 -0.03 -206.55% -507.67%
EPS -0.01 -0.00 -0.24 -200.00% 95.00%
* Standalone data
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 48.77 5.02 0.00 871.22% -
EBITDA 36.32 -4.38 46.03 930.06% -21.11%
Op. profit margin(%) 73.38 -181.03 - 140.54% -
Net Profit 26.21 -4.87 34.24 638.21% -23.47%
EPS 3.41 -0.63 4.45 641.27% -23.37%
* Standalone data
38.30
4.99%
170.00
6.25%
Logica Infoway board approves unaudited standalone financial results for half-year ended September 30 2026
BSE India
Logica Infoway board of directors approves the unaudited standalone financial results for the half-year ended September 30 2026. The announcement includes the statement of deviation and variation in utilization of funds raised via preferential allotment of shares in March 2025. The board also approves the related party transactions statement and the management discussion and analysis for the period. The statutory auditors provide a limited review report with an unmodified opinion on the financial statements.
logo
Farm Peace Ltd.
14 Nov 2026
40.00
-1.94%
Farm Peace approves unaudited standalone financial results for the half-year ended 30 September 2026
BSE India
Farm Peace reviews and approves its unaudited standalone financial results for the half-year ended 30 September 2026. The announcement confirms the submission of these results in compliance with SEBI Listing Obligations and Disclosure Requirements. The company provides a review report from A Y & Company regarding the half-yearly performance. No specific financial figures or segmental drivers are disclosed in this administrative filing.
Raama Finance submits unaudited standalone financial results for Q2FY27 and half-year ended September 30
BSE India
Raama Finance submits its unaudited standalone financial results for the quarter and half-year ended September 30, 2026. The results include a Limited Review Report issued by the statutory auditors Goyal Nagpal & Co. The filing covers the company's financial standing and statement of assets and liabilities for the period. No specific revenue or profit figures are detailed in the notice.
Sep 2026Jun 2026Sep 2025QoQ%YoY%
Revenue/Sales 19.28 21.31 0.17 -9.49% 11086.08%
EBITDA 2.37 6.84 0.16 -65.42% 1353.13%
Op. profit margin(%) 11.82 32.11 94.43 -63.18% -87.48%
Net Profit 1.86 4.35 0.12 -57.34% 1427.71%
EPS 0.45 0.54 0.01 -16.67% 2920.13%
* Standalone data
29.60
2.07%
Goldline Pharmaceutical board approves unaudited standalone financial results for half year ended September 30
BSE India
Goldline Pharmaceutical approves its unaudited standalone financial results and Statement of Assets and Liabilities for the half year ended September 30, 2026. The board meeting held on November 14, 2026, finalized these results which are now being disseminated on the company website. The filing includes an independent auditor's limited review report on the half-yearly and year-to-date financial results.